A Study of CS1001 in Subjects With Stage III Non-Small Cell Lung Cancer

NCT03728556 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

381

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer Stage III

Interventions

BIOLOGICAL: CS1001 monoclonal antibody
BIOLOGICAL: CS1001 placebo

Sponsor

CStone Pharmaceuticals